Publikationen (49) Publikationen von LORETO VIDAUR TELLO

2024

  1. Author Correction: Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia (Scientific Reports, (2023), 13, 1, (17724), 10.1038/s41598-023-45007-4)

    Scientific Reports

  2. Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults

    European Journal of Internal Medicine, Vol. 119, pp. 93-98

2023

  1. Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study

    Journal of Medical Virology, Vol. 95, Núm. 8

  2. Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia

    Scientific Reports, Vol. 13, Núm. 1

  3. Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit

    Critical Care, Vol. 27, Núm. 1

2022

  1. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia

    ERJ Open Research, Vol. 7, Núm. 1

2019

  1. Factors associated with ventilator-associated events: an international multicenter prospective cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 9, pp. 1693-1699

  2. Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis

    Annals of Intensive Care, Vol. 9, Núm. 1

2018

  1. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study

    Intensive Care Medicine, Vol. 44, Núm. 8, pp. 1212-1220

  2. Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit

    Journal of Critical Care, Vol. 48, pp. 172-177

  3. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2017

  1. Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case–control study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 1, pp. 123-130

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  2. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 1, pp. 196-207

  3. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

    Journal of Infection, Vol. 72, Núm. 2, pp. 143-151

2015

  1. Pneumococcal pneumonia coinfection in critically ill patients with influenza a (H1n1) primary viral pneumonia

    Intensive Care Medicine Experimental

2014

  1. DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?

    Clinical Infectious Diseases, Vol. 58, Núm. 8, pp. 1072-1083

  2. Decrease in Mortality in severe community-acquired pneumococcal pneumonia: Impact of improving antibiotic strategies (2000-2013)

    Chest, Vol. 146, Núm. 1, pp. 22-31